GT Biopharma Correlations

GTBP Stock

USD 2.26 0.14 5.83%

The correlation of GT Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

GT Biopharma Correlation With Market

Average diversification

The correlation between GT Biopharma and DJI is 0.11 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding GT Biopharma and DJI in the same portfolio, assuming nothing else is changed.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GT Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

To learn how to invest in GTBP Stock, please use our How to Invest in GT Biopharma guide.

Moving together with GTBP Stock

0.62

EYEN

Eyenovia

Pair Corr

Moving against GTBP Stock

0.5	FNA	Paragon 28	Pair Corr
0.49	OPT	Opthea	Pair Corr
0.35	RGEN	Repligen Potential Growth	Pair Corr
0.33	CPIX	Cumberland Pharmaceuticals	Pair Corr
0.53	NYXH	Nyxoah	Pair Corr
0.52	NVRO	Nevro Corp	Pair Corr
0.49	NPCE	Neuropace	Pair Corr
0.38	LUCD	Lucid Diagnostics Buyout Trend	Pair Corr
0.37	MASI	Masimo	Pair Corr
0.34	INGN	Inogen Inc	Pair Corr
0.62	TMCI	Treace Medical Concepts	Pair Corr
0.6	TOI	Oncology Institute Earnings Call This Week	Pair Corr
0.54	SWZNF	Schweizerische Nationalbank	Pair Corr

Related Correlations Analysis

	ALLR	NRBO	HILS	VRAX	QNRX	PBLA	VRPX	REVB	BDRX	PRAX
ALLR		-0.43	0.0	0.26	0.08	0.0	0.29	0.1	0.35	0.28	ALLR
NRBO	-0.43		0.0	-0.19	-0.16	0.0	-0.24	-0.17	-0.35	-0.28	NRBO
HILS	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	HILS
VRAX	0.26	-0.19	0.0		0.58	0.0	0.75	0.8	0.61	0.56	VRAX
QNRX	0.08	-0.16	0.0	0.58		0.0	0.73	0.83	0.41	0.32	QNRX
PBLA	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	PBLA
VRPX	0.29	-0.24	0.0	0.75	0.73	0.0		0.75	0.76	0.72	VRPX
REVB	0.1	-0.17	0.0	0.8	0.83	0.0	0.75		0.47	0.39	REVB
BDRX	0.35	-0.35	0.0	0.61	0.41	0.0	0.76	0.47		0.88	BDRX
PRAX	0.28	-0.28	0.0	0.56	0.32	0.0	0.72	0.39	0.88		PRAX
	ALLR	NRBO	HILS	VRAX	QNRX	PBLA	VRPX	REVB	BDRX	PRAX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

PRAX	+ 0.88	BDRX
REVB	+ 0.83	QNRX
REVB	+ 0.8	VRAX
BDRX	+ 0.76	VRPX
VRPX	+ 0.75	VRAX
REVB	+ 0.75	VRPX

High negative correlations

NRBO	- 0.43	ALLR
BDRX	- 0.35	NRBO
PRAX	- 0.28	NRBO
VRPX	- 0.24	NRBO
VRAX	- 0.19	NRBO
REVB	- 0.17	NRBO

Risk-Adjusted Indicators

There is a big difference between GTBP Stock performing well and GT Biopharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze GT Biopharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ALLR	5.62	0.25	0.04	0.36	6.13	(7.09)	14.58	(11.82)	47.01
NRBO	4.30	0.77	0.20	(3.32)	3.81	(5.43)	12.50	(6.83)	24.54
HILS	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
VRAX	6.21	(0.21)	0.00	0.07	0.00	0.00	16.67	(11.98)	59.66
QNRX	5.50	(1.14)	0.00	2.46	0.00	0.00	14.29	(10.53)	57.78
PBLA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
VRPX	5.63	(1.18)	0.00	(1.75)	0.00	0.00	10.53	(15.38)	56.86
REVB	5.72	(0.84)	0.00	(1.89)	0.00	0.00	11.78	(12.73)	66.25
BDRX	4.73	(0.57)	0.00	(0.34)	0.00	0.00	11.58	(11.63)	52.99
PRAX	4.16	(0.66)	0.00	(0.80)	0.00	0.00	5.68	(13.08)	51.59

GT Biopharma Corporate Management

Michael Breen	Interim Chairman	Profile
Manu Ohri	Chief Officer	Profile
Jeffrey MD	Consulting Advisor	Profile
Gregory MD	Chief RD	Profile
MPH MBA	VP Management	Profile
PharmD MBA	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC